Redmile Group, LLC

CIK 0001425738 · Q2 2026

13F Equity AUM

$1.5B

-1.4% QoQ

Positions

+4 QoQ

AUM Rank

#1,891

Top 22%

Skill Alpha (FF)

+2.7%/yr^ns

No Clear Edge

Rank #1,126 · Top 14%

vs S&P -4.1%/yr (unadj.)

Quarters Tracked

~13 years

Portfolio Concentration

Top 5: 54.0%Top 10: 73.5%Top 20: 90.0%

SRRK15.9%

KRYS15.8%

STOK8.7%

IMNM7.0%

NRIX6.6%

ABSI5.2%

ANNX4.5%

RGNX3.5%

STTK3.2%

NGNE3.0%

Others (29)26.5%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare97.1%

Unclassified2.9%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 39Median: 1.07%Avg: 2.56%

0–0.5%

9(2.5%)

0.5–1%

8(5.5%)

1–3%

13(21.6%)

3–5%

3(11.3%)

5%+

6(59.2%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 39vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New4Increased5Decreased23Exited0

New Positions

CLYM1.1%

+1.2M

AURA0.8%

+1.7M

ODYSSEY THERAPEUTICS…0.5%

+425K

IM8N0.4%

+51K

Increased

AGOMAB THERAPEUTICS …2.4%

+2.6M(+1650%)

STTK3.2%

+1.4M(+24%)

TCE21.1%

+172K(+66%)

IDYA1.6%

+119K(+23%)

BMRN1.0%

+91K(+53%)

Decreased

SRRK15.9%

-4,755,529(-52%)

ADCT0.8%

-3,943,792(-25%)

NRIX6.6%

-3,659,021(-47%)

ANNX4.5%

-2,679,891(-18%)

ABSI5.2%

-1,513,641(-18%)

IMNM7.0%

-647,295(-12%)

ALXO1.0%

-571,684(-7%)

STOK8.7%

-218,200(-5%)

PRME0.3%

-201,200(-13%)

COGT1.3%

-184,715(-27%)

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...